Humphrey S J, Ludens J H, Perricone S C, Skaletzky L L, Graham B E, Zins G R
Upjohn Laboratories, Upjohn Company, Kalamazoo, MI, USA.
Methods Find Exp Clin Pharmacol. 1995 May;17(4):255-66.
U-37883A is a K+ sparing diuretic which selectively blocks openers of vascular ATP-sensitive K channels. Many N'-disubstituted morpholinoguanidine (N'-DMG) analogs of U-37883A were synthesized and tested for diuretic activity. In conscious rats, 10-100 mg/kg orally of the most active N'-DMGs increased urine volume (V) and Na+ excretion by up to 4-fold with little kaliuresis. The N'-DMGs U-37997A and U-38658A were less potent than standard diuretics, but did not induce the K+ loss seen with hydrochlorothiazide and furosemide or the K+ retention of amiloride and triamterene. In conscious dogs, 10 mg/kg i.v. of the N'-DMGs U-40389A and U-52090 increased V and Na+ excretion by over 7-fold with little kaliuresis. Despite their attractive diuresis, all of the N'-DMGs had narrow margins of safety. Reflecting their direct myocardial depressant action, in isolated rat hearts, bolus intracoronary U-37883A, U-18177A, and U-38658A (0.25-10 mumol) severely reduced the rate (-10 to -100%) and force (-9 to -100%) of contraction. These studies characterize the eukalemic diuretic activity of N'-DMG analogs of U-37883A, and demonstrate the marked cardiac depression characteristic of the morpholinoguanidine diuretic series.
U - 37883A是一种保钾利尿剂,它能选择性地阻断血管ATP敏感性钾通道的开放剂。合成了许多U - 37883A的N'-二取代吗啉胍(N'-DMG)类似物,并对其利尿活性进行了测试。在清醒大鼠中,口服10 - 100mg/kg活性最强的N'-DMG可使尿量(V)和钠排泄量增加高达4倍,而尿钾排泄很少。N'-DMG U - 37997A和U - 38658A的效力低于标准利尿剂,但不会引起氢氯噻嗪和呋塞米导致的钾流失,也不会出现阿米洛利和氨苯蝶啶导致的钾潴留。在清醒犬中,静脉注射10mg/kg的N'-DMG U - 40389A和U - 52090可使V和钠排泄量增加超过7倍,而尿钾排泄很少。尽管它们具有诱人的利尿作用,但所有N'-DMG的安全范围都很窄。在离体大鼠心脏中,冠状动脉内推注U - 37883A、U - 18177A和U - 38658A(0.25 - 10μmol)会严重降低收缩速率(-10%至-100%)和收缩力(-9%至-100%),这反映了它们直接的心肌抑制作用。这些研究描述了U - 37883A的N'-DMG类似物的正血钾性利尿活性,并证明了吗啉胍利尿剂系列具有显著的心脏抑制特性。